• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颗粒酶B在类风湿性关节炎中切割肌腱蛋白-C以释放其C末端结构域。

Granzyme B cleaves tenascin-C to release its C-terminal domain in rheumatoid arthritis.

作者信息

Aubert Alexandre, Liu Amy, Kao Martin, Goeres Jenna, Richardson Katlyn C, Nierves Lorenz, Jung Karen, Nabai Layla, Zhao Hongyan, Orend Gertraud, Krawetz Roman, Lange Philipp F, Younger Alastair, Chan Jonathan, Granville David J

机构信息

International Collaboration on Repair Discoveries (ICORD) Centre, British Columbia Professional Firefighters' Burn and Wound Healing Group, Vancouver Coastal Health Research Institute, and.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

JCI Insight. 2024 Oct 30;9(23):e181935. doi: 10.1172/jci.insight.181935.

DOI:10.1172/jci.insight.181935
PMID:39475853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11623945/
Abstract

Rheumatoid arthritis (RA) is a common autoimmune disorder characterized by exacerbated joint inflammation. Despite the well-documented accumulation of the serine protease granzyme B (GzmB) in RA patient biospecimens, little is understood pertaining to its role in pathobiology. In the present study, tenascin-C (TNC) - a large, pro-inflammatory extracellular matrix glycoprotein - was identified as a substrate for GzmB in RA. GzmB cleaves TNC to generate 3 fragments in vitro: a 130 kDa fragment that remains anchored to the matrix and 2 solubilized fragments of 70 and 30 kDa. Mass spectrometry results suggested that the 30 kDa fragment contained the pro-inflammatory TNC C-terminal fibrinogen-like domain. In the synovial fluids of patients with RA, soluble levels of GzmB and TNC were significantly elevated compared with healthy controls. Further, immunoblotting revealed soluble 70 and 30 kDa TNC fragments in the synovial fluids of patients with RA, matching TNC fragment sizes generated by GzmB cleavage in vitro. Granzyme K (GzmK), another serine protease of the granzyme family, also cleaves TNC in vitro; however, the molecular weights of GzmK-generated TNC fragments did not correspond to TNC fragment sizes detected in patients. Our data support that GzmB, but not GzmK, contributes to RA through the cleavage of TNC.

摘要

类风湿性关节炎(RA)是一种常见的自身免疫性疾病,其特征是关节炎症加剧。尽管在RA患者生物样本中丝氨酸蛋白酶颗粒酶B(GzmB)的积累已有充分记录,但对其在病理生物学中的作用却知之甚少。在本研究中,腱生蛋白-C(TNC)——一种大型促炎性细胞外基质糖蛋白——被确定为RA中GzmB的底物。GzmB在体外切割TNC产生3个片段:一个130 kDa的片段仍锚定在基质上,以及2个70 kDa和30 kDa的可溶性片段。质谱结果表明,30 kDa片段包含促炎性TNC C端纤维蛋白原样结构域。在RA患者的滑液中,GzmB和TNC的可溶性水平与健康对照相比显著升高。此外,免疫印迹显示RA患者滑液中存在可溶性70 kDa和30 kDa的TNC片段,与体外GzmB切割产生的TNC片段大小相符。颗粒酶K(GzmK)是颗粒酶家族的另一种丝氨酸蛋白酶,也能在体外切割TNC;然而,GzmK产生的TNC片段的分子量与患者中检测到的TNC片段大小不对应。我们的数据支持GzmB而非GzmK通过切割TNC导致RA。

相似文献

1
Granzyme B cleaves tenascin-C to release its C-terminal domain in rheumatoid arthritis.颗粒酶B在类风湿性关节炎中切割肌腱蛋白-C以释放其C末端结构域。
JCI Insight. 2024 Oct 30;9(23):e181935. doi: 10.1172/jci.insight.181935.
2
Tenascin-C in Osteoarthritis and Rheumatoid Arthritis.Tenascin-C 在骨关节炎和类风湿关节炎中的作用。
Front Immunol. 2020 Sep 30;11:577015. doi: 10.3389/fimmu.2020.577015. eCollection 2020.
3
Role of the granzyme family in rheumatoid arthritis: Current Insights and future perspectives.颗粒酶家族在类风湿关节炎中的作用:当前的认识和未来的展望。
Front Immunol. 2023 Feb 16;14:1137918. doi: 10.3389/fimmu.2023.1137918. eCollection 2023.
4
Raised circulating tenascin-C in rheumatoid arthritis.类风湿关节炎患者循环中肌腱蛋白-C水平升高。
Arthritis Res Ther. 2012 Nov 29;14(6):R260. doi: 10.1186/ar4105.
5
Increased intra-articular granzyme M may trigger local IFN-λ1/IL-29 response in rheumatoid arthritis.关节内颗粒酶 M 的增加可能会引发类风湿关节炎中的局部 IFN-λ1/IL-29 反应。
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):220-226. doi: 10.55563/clinexprheumatol/ffb107. Epub 2019 Jun 6.
6
Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis.类风湿关节炎中 T 和 B 细胞对瓜氨酸化 tenascin-C 肽的共同识别。
JCI Insight. 2021 Mar 8;6(5):145217. doi: 10.1172/jci.insight.145217.
7
The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA).类风湿性关节炎(RA)患者血浆和滑液中可溶性颗粒酶A和B的水平升高。
Clin Exp Immunol. 1999 May;116(2):366-70. doi: 10.1046/j.1365-2249.1999.00881.x.
8
Expression of large tenascin-C splice variants in synovial fluid of patients with rheumatoid arthritis.类风湿关节炎患者滑液中Tenascin-C大剪接变体的表达
J Orthop Res. 2007 May;25(5):563-8. doi: 10.1002/jor.20366.
9
A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis.颗粒酶B中的一种基因变异与类风湿关节炎中关节破坏的进展相关。
Arthritis Rheum. 2013 Mar;65(3):582-9. doi: 10.1002/art.37808.
10
Granzyme K CD8 T cells form a core population in inflamed human tissue.颗粒酶 K+CD8+T 细胞构成人炎症组织内的核心细胞群。
Sci Transl Med. 2022 Jun 15;14(649):eabo0686. doi: 10.1126/scitranslmed.abo0686.

引用本文的文献

1
Potential implications of granzyme B in keloids and hypertrophic scars through extracellular matrix remodeling and latent TGF-β activation.颗粒酶B通过细胞外基质重塑和潜伏性转化生长因子-β激活在瘢痕疙瘩和增生性瘢痕中的潜在影响。
Front Immunol. 2025 Jan 16;15:1484462. doi: 10.3389/fimmu.2024.1484462. eCollection 2024.

本文引用的文献

1
Granzyme serine proteases in inflammation and rheumatic diseases.颗粒酶丝氨酸蛋白酶在炎症和风湿性疾病中的作用。
Nat Rev Rheumatol. 2024 Jun;20(6):361-376. doi: 10.1038/s41584-024-01109-5. Epub 2024 Apr 30.
2
Molecular and clinicopathological features of granzyme B-negative extranodal NK/T-cell lymphoma.颗粒酶 B 阴性结外 NK/T 细胞淋巴瘤的分子和临床病理特征。
Hum Pathol. 2024 Jan;143:10-16. doi: 10.1016/j.humpath.2023.11.005. Epub 2023 Nov 23.
3
The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis.
MIDORA 试验:一项 II 期、随机、双盲、安慰剂对照、旨在深入了解机制并优化剂量的研究,评估了达佐利单抗在类风湿关节炎患者中的疗效和安全性。
RMD Open. 2023 Aug;9(3). doi: 10.1136/rmdopen-2023-003317.
4
Granzyme B Contributes to Choroidal Neovascularization and Age-Related Macular Degeneration Through Proteolysis of Thrombospondin-1.颗粒酶 B 通过水解血栓素-1 促进脉络膜新生血管形成和年龄相关性黄斑变性。
Lab Invest. 2023 Jun;103(6):100123. doi: 10.1016/j.labinv.2023.100123. Epub 2023 Feb 26.
5
Cytotoxic CD8 T cells target citrullinated antigens in rheumatoid arthritis.细胞毒性 CD8 T 细胞靶向类风湿关节炎中的瓜氨酸化抗原。
Nat Commun. 2023 Jan 19;14(1):319. doi: 10.1038/s41467-022-35264-8.
6
Granzyme B as a therapeutic target: an update in 2022.颗粒酶 B 作为治疗靶点:2022 年的最新进展。
Expert Opin Ther Targets. 2022 Nov;26(11):979-993. doi: 10.1080/14728222.2022.2161890. Epub 2022 Dec 27.
7
Noncytotoxic Roles of Granzymes in Health and Disease.颗粒酶在健康与疾病中的非细胞毒性作用
Physiology (Bethesda). 2022 Nov 1;37(6):323-348. doi: 10.1152/physiol.00011.2022. Epub 2022 Jul 12.
8
Granzyme K CD8 T cells form a core population in inflamed human tissue.颗粒酶 K+CD8+T 细胞构成人炎症组织内的核心细胞群。
Sci Transl Med. 2022 Jun 15;14(649):eabo0686. doi: 10.1126/scitranslmed.abo0686.
9
Structural insights into the catalytic mechanism of granzyme B upon substrate and inhibitor binding.解析底物和抑制剂结合时颗粒酶 B 的催化机制的结构见解。
J Mol Graph Model. 2022 Jul;114:108167. doi: 10.1016/j.jmgm.2022.108167. Epub 2022 Mar 22.
10
Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, "MAREMO".通过靶向基质调节基序 "MAREMO" 调节 tenascin-C 功能。
Matrix Biol. 2022 Apr;108:20-38. doi: 10.1016/j.matbio.2022.02.007. Epub 2022 Feb 26.